International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Drugs Banned for Use in Food Animals: An Explanation

Author(s): Davidson Gigi S

Issue: Mar/Apr 2001 - Compounding for Animals
View All Articles in Issue

Page(s): 101-103

Drugs Banned for Use in Food Animals: An Explanation Page 1

Drugs Banned for Use in Food Animals: An Explanation Page 2

Drugs Banned for Use in Food Animals: An Explanation Page 3

Download in electronic PDF format for $75

Abstract: Because of potential adverse effects on human health, some drugs are prohibited by the US Food and Drug Administration from use in food animals. The author discusses these drugs and drug classes (diethylstilbestrol, chloramphenicol, nitroimidazoles, sulfonamides [in dairy cattle], nitrofurans (furazolidone and nitrofurazone), clenbuteral, dipyrone, fluoroquinolones (enrofloxacin, ciprofloxacin, sarafloxacin) and glycopeptides (vancomycin). She also briefly describes the hazards to humans that each can cause, and she discusses avoidance of violative tissue residues of allowable drugs in food-producing animals.

Related Keywords: animal drugs, Animal Medicinal Drug Use Clarification Act, banned drugs, cattle, chickens, dairy cattle, drug hazards, food animals, food-producing animals, live stock, pigs, prohibited drugs

Related Categories: LEGAL, VETERINARY, FDA

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S	Mar/Apr 2001 Pg. 101-103
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
When is Compounding for Animals Legal? Siegner A Wes Jr	May/Jun 1999 Pg. 188-191
When to Compound Medications for Veterinary Patients Forsythe Lauren Eichstadt	Jan/Feb 2017 Pg. 19-21
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)	Nov/Dec 2016 Pg. 457-458
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 294-298
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W	May/Jun 2016 Pg. 202-206
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr	Mar/Apr 2011 Pg. 92
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
Return to Top